Nightingale Health is a pioneering brand that utilizes advanced blood analysis technology to go beyond individual biomarkers, offering a direct connection to disease risks and accurate predictions of future health. By combining their in-house created technology with global health databases and world-leading medical research, Nightingale Health provides comprehensive and highly accurate biomarker results quickly and at a low cost on a mass scale. Their technology works by analyzing blood samples using proprietary blood testing technology.

This fully automated process captures hundreds of molecules, producing up to 250 times more molecular health data than regular blood tests. Nightingale Health's analysis measures various biomarkers such as amino acids, cholesterols, inflammation, and more. These results are compared against a global database, allowing for the prediction of disease risks based on real-life data.

Nightingale Health operates under certified quality management systems and ensures data quality through external quality assurance programs. Their technology is widely used in world-class epidemiological and genetic studies, with over 450 publications utilizing their services. For researchers interested in using their technology for medical research, Nightingale Health offers specialized analysis services.

With their commitment to accuracy, quality, and innovation, Nightingale Health provides a revolutionary approach to health analysis and disease prediction